Objectives: To determine the economic and clinical outcomes associated with infection with vancomycin-resistant Enterococcus (VRE) and to compare these outcomes to those associated with infection with vancomycin-sensitive Enterococcus (VSE
CommentsThe group at John's Hopkins University assessed economic and clinical outcomes associated with infection caused by vancomycin-resistant enterococci (VRE) and compared them with infections associated with vancomycin-sensitive enterococci (VSE) in a 3-month prospective cohort study of high-risk critically ill patients. 1 Of interest to the liver transplant community is that factors shown to be associated with increased intensive care unit cost were liver transplantation and infection with either VRE or VSE. However, overall, VRE infections were associated with a mean increased cost per day of $304.There are two primary limitations to this study. One is the small number of patients studied who had invasive infection with VRE as the only pathogen. Second, the investigators included sites other than bloodstream in the analysis, which, in the context of multiple potential pathogens recovered from a given site, may have overrepresented the contribution of the enterococcus. Third, 6 of the 12 patients with invasive VRE also were infected with VSE, thus dramatically reducing the number of patients studied. Nevertheless, this is a useful study because it documents the increased cost associated with VRE infections.There is debate over the mortality or increased morbidity risk with infection caused by VRE. In a prospective, multicenter, observational study of more than 400 patients with enterococcal bacteremia, we showed there was a twofold increased risk for mortality, independent of severity of illness or other factors, 2 for patients with VRE bacteremia compared with patients with VSE bacteremia. 2 We also showed that early therapy with an agent directed against VRE was associated with a better outcome compared with those initially treated with an inactive agent. 2 These data underscore the need for early identification and treatment of VRE infection.In the liver transplantation setting, VRE usually is acquired nosocomially through either long pretransplantation hospitalization or postoperatively in the intensive care unit. Many patients remain asymptomatically colonized, and as yet, there is no good strategy for the elimination of colonization. Most infections arise in previously colonized individuals. The primary means of prevention remains good infection control. We also have shown that the environment is extremely important in the transmission of VRE from patient to patient or environment to patient. 3 Hand washing and environmental cleaning, along with identification of carriers, isolation, or appropriate precautions, remain the mainstays of prevention.Once colonized with VRE, there is no a clear assessment of risk factors for the occurrence of invasive disease in liver transplantation. Studies to assess such factors should be undertaken.Once patients have evidenc...